A Novel KRAS Antibody Highlights a Regulation Mechanism of Post-Translational Modifications of KRAS during Tumorigenesis
KRAS is a powerful oncogene responsible for the development of many cancers. Despite the great progress in understanding its function during the last decade, the study of KRAS expression, subcellular localization, and post-translational modifications remains technically challenging. Accordingly, man...
Main Authors: | Mohamad Assi, Boris Pirlot, Vincent Stroobant, Jean-Paul Thissen, Patrick Jacquemin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/17/6361 |
Similar Items
-
Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
by: Ke Xu, et al.
Published: (2019-04-01) -
Simplified structural map of Kras Kras (Slovene), Carso (Italian) = Geographical unit
by: Ladislav Placer
Published: (2015-07-01) -
The cooperation of the tumor suppressor gene Dlc1 and the oncogene Kras in tumorigenesis
by: Buse, Cordula
Published: (2012) -
The cooperation of the tumor suppressor gene Dlc1 and the oncogene Kras in tumorigenesis
by: Buse, Cordula
Published: (2012) -
Hes1 plays an essential role in Kras-driven pancreatic tumorigenesis
by: Nishikawa, Yoshihiro
Published: (2019)